Composition : Cipro-A® 250 : Ciprofloxacin (as hydrochloride) USP 250 mg.
Cipro-A® 500 : Ciprofloxacin (as hydrochloride) USP 500 mg
Cipro-A® 750 : Ciprofloxacin (as hydrochloride) USP 750 mg
Cipro-A® pellets for Suspension : Ciprofloxacin 250 mg / 5 ml
Cipro-A® IV Infusion : Ciprofloxacin 200 mg / 100 ml
Indication : Respiratory tract infections, Skin and soft tissue infections, Urinary tract infections, Gonorrhea and other sexually transmitted diseases, Bacterial gastrointestinal infections, Bone and joint infections, Osteomyelitis, Surgical prophylaxis, Other infections.
Dosage & Administration : According to the type of infection 250 – 750 mg ciprofloxacin with 12 hours interval. In children, 10 – 20 mg / kg with 12 hours interval. Generally ciprofloxacin should be continued for at least 2 days after the signs and symptoms have disappeared, except for inhalational anthrax (Post – exposure).Patients whose therapy is started with Ciprofloxacin I.V. may be switched to Ciprofloxacin Tablets or Suspension when clinically indicated at the discretion of the physician.